These findings show that miR-181b inhibition exerts protective effects on aneurysm formation/progression at multiple susceptible sites within the aorta, even in the absence of overt inflammation, implying additional beneficial effects of miR-181b inhibition independent of increased TIMP-3 protein expression. This evidence concerns the gene TIMP3 and aneurysm.